Beyond Air (XAIR) Stock: Buy, Sell, or Hold?
XAIR - Beyond Air, Inc. Common Stock
$2.34
0.15 (6.85%)
▲
5d:
+11.43%
30d:
-26.88%
90d:
-57.22%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 09, 2026
17d
Get Alerted When XAIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XAIR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XAIR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XAIR is currently trading at $2.34, which is considered slightly low relative to its 30-day fair value range of $2.29 to $3.06.
Technical Outlook: Technically, XAIR is in a uptrend. Immediate support is located at $2.05, while resistance sits at $2.76. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: XAIR scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.00 (+754.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XAIR is in a uptrend. Immediate support is located at $2.05, while resistance sits at $2.76. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: XAIR scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.00 (+754.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.29 -
$3.06
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 754.7% below Wall St target ($20.00)
- CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$2.29 -
$3.06
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.05
Resistance Level
$2.76
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.31
Wall Street Target
$20.00
(+754.7%)
Revenue Growth (YoY)
0.5%
Share & Embed Analysis
Last updated: October 22, 2026 8:51 AM ET
Data refreshes hourly during market hours. Next update: 9:51 AM
Data refreshes hourly during market hours. Next update: 9:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XAIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
